Investing in Health and Medical Research – Medical Research Future Fund 10 year investment plan

Page last updated: 02 April 2019

Investing in Health and Medical Research – Medical Research Future Fund 10 year investment plan (PDF 205 KB)

The Government will continue its commitment to supporting lifesaving medical research with a $5 billion 10-year investment plan from the Medical Research Future Fund (MRFF). It will place Australia at the leading edge of research in areas like genomics and will support the search for cures and treatments, including for rare cancers.

The plan is underpinned by four key themes – patients, researchers, translation and missions. This includes $614 million for Clinical Trials for Rare Cancers, Rare Diseases and Unmet Needs.

Developing new drugs, devices, treatments and cures may take more than a decade. This 10-year plan will give researchers and industry certainty and direction and will reaffirm Australia’s reputation as a world leader in medical research. With this in mind, funding for all existing MRFF programs will be continued.

This 10-year plan builds on $3.5 billion in health and medical research funding provided through the National Health and Medical Research Council, and the $500 million Biomedical Translation Fund.

Why is this important?

Today’s research is tomorrow’s health care. There is no better way to ensure Australians receive the highest quality health care than by investing in medical research. These new programs will harness innovation, deliver more clinical trials, provide vital infrastructure and improve patient outcomes.

Who will benefit?

People will be able to access cutting edge therapies and health services. Researchers and industry will also benefit through ongoing support for their vital work.

How much will this cost?

This will cost $5 billion. The funds are disbursements from the ongoing $20 billion MRFF endowment fund.

Medical Research Future Fund 10 Year Plan


Projects
2018–19
$m
2019–20
$m
2020–21
$m
2021–22
$m
2022–23
$m
2023–24
$m
2024–25
$m
2025–26
$m
2026–27
$m
2027–28
$m
Total over 10 Years
$m
Patients
97.8
124.4
140.3
146.5
135.1
129.1
125.6
125.6
125.6
125.6
1,275.6
Emerging Priorities and Consumer Driven Research (EPCD)
53.7
54.3
71.2
80.9
69.5
63.5
60.0
60.0
60.0
60.0
633.0
Clinical Trials for Rare Cancers, Rare Diseases and Unmet Needs (RCRDUN)
42.3
67.1
66.5
62.6
62.6
62.6
62.6
62.6
62.6
62.6
614.2
Global Health - Tackling Antimicrobial Resistance and Drug Resistant Tuberculosis
1.8
3.0
2.7
3.0
3.0
3.0
3.0
3.0
3.0
3.0
28.4
Researchers
4.3
49.8
92.6
102.1
94.0
90.0
90.0
90.0
90.0
90.0
792.8
Frontier Health and Medical Research
-
20.0
60.0
70.0
70.0
70.0
70.0
70.0
70.0
70.0
570.0
Industry Researcher Exchange and Training
-
8.0
10.0
10.0
4.0
-
-
-
-
-
32.0
Clinical Researchers
4.3
21.8
22.6
22.1
20.0
20.0
20.0
20.0
20.0
20.0
190.8
Missions
47.8
140.6
175.7
166.9
161.9
148.0
148.0
138.0
138.0
119.2
1,384.0
Australian Brain Cancer Mission $123.6 million (including $65.3m in philanthropic contributions, $5.0 m in RCRDUN clinical trials funding and $3.4m in EPCD research funding and $1.0m in 2017–18)
9.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
-
49.0
Million Minds Mental Health Research Mission
5.0
5.0
15.0
15.0
25.0
15.0
20.0
10.0
10.0
5.0
125.0
Genomics Health Futures Mission
8.8
56.6
68.7
69.9
54.9
50.0
50.0
50.0
50.0
41.2
500.0
Ageing, Aged Care and Dementia Mission $185 million (incl $17.5m in 28–29)
10.0
17.5
17.5
17.5
17.5
17.5
17.5
17.5
17.5
17.5
167.5
Indigenous Health Futures $160 million (incl 12.5m in 28–29)
15.0
22.5
22.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
147.5
Stem Cell Mission
-
6.0
18.0
18.0
18.0
18.0
18.0
18.0
18.0
18.0
150.0
Cardiovascular Mission $220 million (incl $20m in 28–29)
-
23.0
24.0
24.0
24.0
25.0
20.0
20.0
20.0
20.0
200.0
Traumatic Brain Injury Mission $50 million (incl $5m in 28–29)
-
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
45.0
Translation
54.2
77.8
171.2
212.0
176.5
173.5
163.5
163.5
163.8
163.8
1,519.7
Preventative and Public Health Research
18.8
32.5
57.1
33.5
29.5
26.5
15.5
15.5
15.8
15.8
260.4
Primary Health Care Research
-
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
45.0
Rapid Applied Research Translation Centres
20.0
20.0
20.0
22.0
22.0
22.0
23.0
23.0
23.0
23.0
218.0
Medical Research Commercialisation
15.4
15.3
35.3
35.3
35.0
35.0
35.0
35.0
35.0
35.0
311.3
National Critical Infrastructure
-
5.0
43.8
106.2
75.0
75.0
75.0
75.0
75.0
75.0
605.0
Data Infrastructure - Registries, biobanks, linkage platforms
-
-
10.0
10.0
10.0
10.0
10.0
10.0
10.0
10.0
80.0
Total
204.1
392.5
579.8
627.5
567.5
540.6
527.1
517.1
517.4
498.6
4,972.1
TOTAL 10 YEAR PLAN (incl $65.3 m philanthropic, $1.0m in 17–18 and $55m in 28–29)
5,093.4
Balance over the forward estimates
18.3
3.5
0.1
18.5
82.6
Funds from the $20 billion MRFF endowment fund will continue
to be disbursed beyond the forward estimates
Current disbursements over the forward estimates
222.4
396.0
579.9
646.0
650.0